Ownership history in RS CRUM INC. · 4 quarters on record
This page tracks every 13F SEC filing in which RS CRUM INC. reported a position in CALIDI BIOTHERAPEUTICS INC (CLDI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 20,256 | +5,000 | +32.8% | 0.00% | $24K | $1.17 |
| 2025 Q3 | REDUCED | 15,256 | -40,057 | -72.4% | 0.01% | $23K | $1.52 |
| 2025 Q1 | ADDED | 55,313 | +14,850 | +36.7% | 0.01% | $31K | $6.79 |
| 2024 Q4 | INITIATED | 40,463 | — | — | 0.01% | $47K | $13.80 |
As of 2025 Q4 — sorted by position size